Dendreon Analysts Getting Very Skeptical
Seeking Alpha
Dendreon: Picking Through the Carnage (video)
Motley Fool
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
- AbbVie
- Achillion
- Aegerion
- Amarin
- Arena Pharmaceuticals
- AstraZeneca
- Aveo Pharmaceutical
- Biogen Idec
- Bristol-Myers Squibb
- Delcath
- Dendreon
- Depomed
- Gilead
- GSK
- Merck
- NewLink Genetics
- Raptor Pharmaceuticals
- Rigel
- Sangamo BioSciences
- Sucampo
- Titan Pharmaceuticals
- Valeant Pharmaceuticals
- Vertex Pharmaceuticals
- Vivus
- Zogenix
Understanding Why Cancer Vaccines Fail
Motley Fool
ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
Seeking Alpha
Will Dendreon Continue to Plummet?
Wall St. Cheat Sheet